Atlas Trials

Dose-escalation Study of Oral Administration of S 55746 in Patients With Chronic Lymphocytic Leukaemia and B-Cell Non-Hodgkin Lymphoma

Clinical trial NCT02920697 · COMPLETED

Trial details

NCT number
NCT02920697
Sponsor
Institut de Recherches Internationales Servier
Status
COMPLETED
Phase
Phase 1
Study type
INTERVENTIONAL
Chronic Lymphocytic Leukaemia (CLL)B-Cell Non-Hodgkin Lymphoma (NHL)Multiple Myeloma (MM)
Start date
2014-03-01
Primary completion
2018-10-22
Enrollment
65

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.